Systemic Mastocytosis Treatment Market Report

Global and Region Systemic Mastocytosis Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：177
  • REPORT CODE：GMM940911
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Systemic Mastocytosis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Systemic Mastocytosis Treatmentmarket, defines the market attractiveness level of Systemic Mastocytosis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Systemic Mastocytosis Treatment industry, describes the types of Systemic Mastocytosis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Systemic Mastocytosis Treatment market and the development prospects and opportunities of Systemic Mastocytosis Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Systemic Mastocytosis Treatment market in Chapter 13.

    By Player:

    • AbbVie Inc

    • Deciphera Pharmaceuticals LLC

    • Blueprint Medicines Corp

    • Bristol-Myers Squibb Company

    • AB Science SA

    • Seattle Genetics Inc

    • Arog Pharmaceuticals Inc

    • Novartis AG

    • Patara Pharma Inc

    • Stemline Therapeutics Inc

    By Type:

    • AK-002

    • BLU-285

    • Brentuximab Vedotin

    • Crenolanib Besylate

    • Cromolyn Sodium

    • Others

    By End-User:

    • Clinics

    • Hospitals

    • Homecare

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Systemic Mastocytosis Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Systemic Mastocytosis Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Systemic Mastocytosis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Systemic Mastocytosis Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Systemic Mastocytosis Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.2 United States Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.3 Europe Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.4 China Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.5 Japan Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.6 India Systemic Mastocytosis Treatment Consumption (2017-2022)

    • 7.7 South Korea Systemic Mastocytosis Treatment Consumption (2017-2022)

    8 Region and Country-wise Systemic Mastocytosis Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.4 China Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.6 India Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Systemic Mastocytosis Treatment Consumption Forecast (2022-2028)

    9 Global Systemic Mastocytosis Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Systemic Mastocytosis Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AK-002 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global BLU-285 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Brentuximab Vedotin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Crenolanib Besylate Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Cromolyn Sodium Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Systemic Mastocytosis Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Homecare Consumption and Growth Rate (2017-2022)

    10 Global Systemic Mastocytosis Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AK-002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global BLU-285 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Brentuximab Vedotin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Crenolanib Besylate Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Cromolyn Sodium Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    11 Global Systemic Mastocytosis Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Systemic Mastocytosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Systemic Mastocytosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Systemic Mastocytosis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Systemic Mastocytosis Treatment Market Competitive Analysis

    • 14.1 AbbVie Inc

      • 14.1.1 AbbVie Inc Company Details

      • 14.1.2 AbbVie Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbbVie Inc Systemic Mastocytosis Treatment Product and Service

    • 14.2 Deciphera Pharmaceuticals LLC

      • 14.2.1 Deciphera Pharmaceuticals LLC Company Details

      • 14.2.2 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product and Service

    • 14.3 Blueprint Medicines Corp

      • 14.3.1 Blueprint Medicines Corp Company Details

      • 14.3.2 Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Blueprint Medicines Corp Systemic Mastocytosis Treatment Product and Service

    • 14.4 Bristol-Myers Squibb Company

      • 14.4.1 Bristol-Myers Squibb Company Company Details

      • 14.4.2 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product and Service

    • 14.5 AB Science SA

      • 14.5.1 AB Science SA Company Details

      • 14.5.2 AB Science SA Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AB Science SA Systemic Mastocytosis Treatment Product and Service

    • 14.6 Seattle Genetics Inc

      • 14.6.1 Seattle Genetics Inc Company Details

      • 14.6.2 Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Seattle Genetics Inc Systemic Mastocytosis Treatment Product and Service

    • 14.7 Arog Pharmaceuticals Inc

      • 14.7.1 Arog Pharmaceuticals Inc Company Details

      • 14.7.2 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product and Service

    • 14.8 Novartis AG

      • 14.8.1 Novartis AG Company Details

      • 14.8.2 Novartis AG Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis AG Systemic Mastocytosis Treatment Product and Service

    • 14.9 Patara Pharma Inc

      • 14.9.1 Patara Pharma Inc Company Details

      • 14.9.2 Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Patara Pharma Inc Systemic Mastocytosis Treatment Product and Service

    • 14.10 Stemline Therapeutics Inc

      • 14.10.1 Stemline Therapeutics Inc Company Details

      • 14.10.2 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Systemic Mastocytosis Treatment

    • Figure Systemic Mastocytosis Treatment Picture

    • Table Global Systemic Mastocytosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Systemic Mastocytosis Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Systemic Mastocytosis Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Systemic Mastocytosis Treatment Consumption by Country (2017-2022)

    • Figure United States Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Systemic Mastocytosis Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Systemic Mastocytosis Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Systemic Mastocytosis Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AK-002 Consumption and Growth Rate (2017-2022)

    • Figure Global BLU-285 Consumption and Growth Rate (2017-2022)

    • Figure Global Brentuximab Vedotin Consumption and Growth Rate (2017-2022)

    • Figure Global Crenolanib Besylate Consumption and Growth Rate (2017-2022)

    • Figure Global Cromolyn Sodium Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global AK-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BLU-285 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brentuximab Vedotin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Crenolanib Besylate Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cromolyn Sodium Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Systemic Mastocytosis Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Systemic Mastocytosis Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Systemic Mastocytosis Treatment Product and Service

    • Table Deciphera Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product and Service

    • Table Blueprint Medicines Corp (Foundation Year, Company Profile and etc.)

    • Table Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blueprint Medicines Corp Systemic Mastocytosis Treatment Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product and Service

    • Table AB Science SA (Foundation Year, Company Profile and etc.)

    • Table AB Science SA Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science SA Systemic Mastocytosis Treatment Product and Service

    • Table Seattle Genetics Inc (Foundation Year, Company Profile and etc.)

    • Table Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seattle Genetics Inc Systemic Mastocytosis Treatment Product and Service

    • Table Arog Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Systemic Mastocytosis Treatment Product and Service

    • Table Patara Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Patara Pharma Inc Systemic Mastocytosis Treatment Product and Service

    • Table Stemline Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US